Celldex Therapeutics, Inc. (CLDX) Earnings
|
Expand Research on CLDX
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +31.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +11.5% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/10/22 | Q222 | N/A | -$0.42 | N/A | N/A | $560K | N/A | N/A | N/A | ||
| 3/7/18 |  |
Q417 | -$0.03 | -$0.25 | +$0.22 | $3.5M | $1.35M | N/A |  | | Details |
| 8/8/17 | |
Q217 | -$0.23 | -$0.27 | +$0.04 | $3.83M | $1.05M | N/A | | | Details |
| 3/14/17 | |
Q416 | -$0.30 | -$0.34 | +$0.04 | $1.97M | $1.08M | N/A | | | Details |
| 11/7/16 | Q316 | -$0.29 | -$0.33 | +$0.04 | $2.2M | $850K | N/A | | | Details | |
8/8/16  |
Q216 | -$0.32 | -$0.34 | +$0.02 | $1.39M | $850K | N/A | | | Details | |
| 2/25/16 |
|
Q415 | -$0.33 | -$0.35 | +$0.02 | $1.8M | $640K | N/A | | | Details |
| 8/10/15 |
|
Q215 | -$0.33 | N/A | N/A | $2.2M | $592K | N/A | | | Details |
